BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 24318983)

  • 1. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.
    Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML
    J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
    Ye C; Shen Z; Greenberg ML
    J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin.
    Abe M; Hasegawa Y; Oku M; Sawada Y; Tanaka E; Sakai Y; Miyoshi H
    J Biol Chem; 2016 Jul; 291(30):15491-502. PubMed ID: 27268057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of branched-chain amino acid aminotransferases rescues the growth defects of cells lacking the Barth syndrome-related gene TAZ1.
    Antunes D; Chowdhury A; Aich A; Saladi S; Harpaz N; Stahl M; Schuldiner M; Herrmann JM; Rehling P; Rapaport D
    J Mol Med (Berl); 2019 Feb; 97(2):269-279. PubMed ID: 30604168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic re-engineering of polyunsaturated phospholipid profile of Saccharomyces cerevisiae identifies a novel role for Cld1 in mitigating the effects of cardiolipin peroxidation.
    Lou W; Ting HC; Reynolds CA; Tyurina YY; Tyurin VA; Li Y; Ji J; Yu W; Liang Z; Stoyanovsky DA; Anthonymuthu TS; Frasso MA; Wipf P; Greenberger JS; Bayır H; Kagan VE; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1354-1368. PubMed ID: 29935382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiolipin function in the yeast S. cerevisiae and the lessons learned for Barth syndrome.
    Ji J; Greenberg ML
    J Inherit Metab Dis; 2022 Jan; 45(1):60-71. PubMed ID: 34626131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
    Gu Z; Valianpour F; Chen S; Vaz FM; Hakkaart GA; Wanders RJ; Greenberg ML
    Mol Microbiol; 2004 Jan; 51(1):149-58. PubMed ID: 14651618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
    Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomics Characterization of Biosynthetic and Remodeling Pathways of Cardiolipins in Genetically and Nutritionally Manipulated Yeast Cells.
    Tyurina YY; Lou W; Qu F; Tyurin VA; Mohammadyani D; Liu J; Hüttemann M; Frasso MA; Wipf P; Bayir H; Greenberg ML; Kagan VE
    ACS Chem Biol; 2017 Jan; 12(1):265-281. PubMed ID: 27982579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular functions of cardiolipin in yeast.
    Joshi AS; Zhou J; Gohil VM; Chen S; Greenberg ML
    Biochim Biophys Acta; 2009 Jan; 1793(1):212-8. PubMed ID: 18725250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking phosphatidylglycerol degradation in yeast defective in cardiolipin remodeling results in a new model of the Barth syndrome cellular phenotype.
    Káňovičová P; Čermáková P; Kubalová D; Bábelová L; Veselá P; Valachovič M; Zahumenský J; Horváth A; Malínský J; Balážová M
    J Biol Chem; 2022 Jan; 298(1):101462. PubMed ID: 34864056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial monolysocardiolipin acyltransferase is elevated in the surviving population of H9c2 cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis.
    Danos M; Taylor WA; Hatch GM
    Biochem Cell Biol; 2008 Feb; 86(1):11-20. PubMed ID: 18364741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth.
    Chen S; He Q; Greenberg ML
    Mol Microbiol; 2008 May; 68(4):1061-72. PubMed ID: 18430085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deacylation on the matrix side of the mitochondrial inner membrane regulates cardiolipin remodeling.
    Baile MG; Whited K; Claypool SM
    Mol Biol Cell; 2013 Jun; 24(12):2008-20. PubMed ID: 23637464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome.
    Malhotra A; Edelman-Novemsky I; Xu Y; Plesken H; Ma J; Schlame M; Ren M
    Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2337-41. PubMed ID: 19164547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiolipin-deficient cells have decreased levels of the iron-sulfur biogenesis protein frataxin.
    Li Y; Lou W; Grevel A; Böttinger L; Liang Z; Ji J; Patil VA; Liu J; Ye C; Hüttemann M; Becker T; Greenberg ML
    J Biol Chem; 2020 Aug; 295(33):11928-11937. PubMed ID: 32636300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a cardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeast.
    Beranek A; Rechberger G; Knauer H; Wolinski H; Kohlwein SD; Leber R
    J Biol Chem; 2009 Apr; 284(17):11572-8. PubMed ID: 19244244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome.
    de Taffin de Tilques M; Tribouillard-Tanvier D; Tétaud E; Testet E; di Rago JP; Lasserre JP
    Dis Model Mech; 2017 Apr; 10(4):439-450. PubMed ID: 28188263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.